You searched for "misdiagnosis"

1200 results found

My ophthalmology elective: East to West

I was fortunate to be able to complete my elective in three different parts of the world: the UK, Vietnam and Pakistan. I spent three weeks at Bristol Eye Hospital (BEH), two weeks at Cho Ray Hospital in Ho Chi...

‘Phaco-plus’ procedures at forefront of modern glaucoma management

Glaucoma and cataract increasingly present as a ‘two-in-one’ surgical opportunity. In the UK, new modelling suggests ~1 million adults aged ≥40 may currently have glaucoma, with a projected rise to ~1.6 million by 2060 as the population ages and demographics...

The visual field of empathy: What ophthalmology taught me about seeing the patient

It was a busy shift on the ward. Amongst the chest pains and fevers was an older woman referred for confusion. She was quiet, polite, and compliant – the kind of patient who doesn’t raise alarms. As we spoke, I...

Inherited retinal disorders now the leading cause of blindness

The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...

Redefining the future of sight - Moorfields Eye Charity launches first major national funding initiative

New grants strategy aims to enable innovation at scale and transform eye health. Moorfields Eye Charity has launched a significant national funding initiative to accelerate the urgent development of new eye health treatments and interventions. The new Discovery and Translation...

Capacity-strengthening for diabetic retinopathy services in low- and middle-income countries

Introduction DR-NET eye health professionals in low- and middle-income countries (LMICs) have, since 2015, been able to access training in diabetic retinopathy (DR) grading provided by Gloucestershire Retinal Education Group (GREG). GREG, led by Professor Peter Scanlon and based at...

Specialty-driven EMR for paperless clinical environment – insights for an informed choice

Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...

Ophthalmology history and examination – a guide for medical students

*First author Students have very little exposure to ophthalmology during their years at medical school. Teaching consists of a handful of lectures followed by a short placement in which students are expected to practise histories and examinations on patients with...

A semi-automated algorithm for identifying glaucoma patients with blindness

Patients with sight impairment (previously referred to as partial sightedness) or severe sight impairment (previously referred to as blindness) are eligible for a certificate of visual impairment (CVI). Certification confers eligibility for a wide range of benefits administered by local...

Ophthalmic mentors: Professor Sir Peng Tee Khaw

In the second of our interviews in this series, Eye News speaks to Professor Sir Peng Tee Khaw, Professor of Glaucoma and Ocular Healing, Consultant Ophthalmic Surgeon, Director of the National Institute for Health Research, Biomedical Research Centre at Moorfields...

From paper to digital: Real lessons for a sustainable NHS digital future

Portsmouth's OpenEyes implementation reveals why healthcare digital transformation needs honest evaluation, proper clinical leadership resourcing and realistic expectations about technology efficiency promises. Like many eye departments across the NHS, we at Portsmouth were drowning in paper. Notes went missing, handwriting...

Semaglutide and vision loss: A new concern for NAION risk?

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...